Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Daniela Trabattoni Added: 2 years ago
A single centre, prospective, non-randomised study from DrDaniela Trabattoni (Monzino Cardiology Centre,Milan, IT) following device implantation of the Occlutech PFO Closure device in 442 consecutive patients.The study is particularly interesting due to the scarcity of data available on the long term follow up (over 5 years after) of device implantation. Also, the results are focussed not only… View more
Research Area(s) / Expertise: Job title: Consultant Interventional Cardiologist
Personal History Dr Mullen is a consultant cardiologist based in London, UK. Academic History Dr. Mullen completed his higher cardiology training in Sheffield, London and Toronto, Canada. He holds an MB BS from the University of Newcastle-upon-Tyne and graduated with his MD from the University of London in 2001.1 Career Overview Dr Mullen is a consultant cardiologist with… View more
Author(s): Sean Lyden Added: 1 year ago
LINC Conference 2025 - 30 day results of the PATCH study suggests the PerQSeal vascular closure device (Vivasure Medical Limited) can be used as an alternative percutaneous procedure for large-bore common femoral access, showing low risk of haematoma and a medium time of 0 minutes to achieve vessel closure.Dr Sean Lyden (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the PATCH single… View more
Author(s): Oussama M Wazni Added: 1 year ago
AHA Conference 2024 - Safety and efficacy outcomes comparing left atrial appendage (LAA) closure with the WATCHMAN FLX device to oral anticoagulation (OAC) following atrial fibrillation (AF) catheter ablation.Dr Oussama Wazni (The Cleveland Clinic Foundation, Ohio, US) joins us onsite at AHA Conference to discuss the findings from OPTION (NCT03795298).OPTION is a prospective, multi-center, multi… View more